NCT00388583 - Study of Inactivated, Split-Virion Influenza Vaccine Compared With Standard Fluzone Vaccine in Elderly Subjects | Biotech Hunter

Enrollment

817

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

June 30, 2007

Study Completion Date

September 30, 2008

Conditions

Orthomyxoviridae InfectionInfluenzaMyxovirus Infection

Interventions

BIOLOGICAL

Split, Inactivated, Trivalent Influenza Vaccine

0.1 mL, Intradermal

BIOLOGICAL

Split, Inactivated, Trivalent Influenza Vaccine

0.5 mL, Intramuscular

Trial Locations (17)

Alabaster

Tucson

Fountain Valley

Pinellas Park

Chicago

Springfield

Brooklyn

New York

Bensalem

Grove City

Johnstown

Pittsburgh

Fort Worth

Galveston

Layton

South Jordan

Norfolk